Results
The mean age of the patients included the study was 64.8 ± 7.5 (51–77) years, the mean time since diagnosis was 78.8 ± 21.9 (48–136) days, and the mean total serum PSA level was 9.8 ± 5.5 (4.1–22) ng/mL. The demographical data of the patients are listed in Table 1. Of the 24 patients whose operations were postponed, 14 (58.3%) patients were in the low-risk group and 10 (41.7%) patients were in the medium-risk group. Fourteen patients have Gleason 3+3, eight patients have Gleason 3 + 4 and 2 patients have Gleason 4 + 3 prostatic adenocarcinoma.
The mean STAI-I score of the patients (46.7 ± 1.4 [44–49]) was significantly higher than their STAI-II score (41.7 ± 2.4 [39–47]) (p < 0.001). The negative correlation between the decrease in age and STAI-I score was found to be statistically significant (r = 0.439, p < 0.05). The mean BDI score of the patients was 4.3 ± 3.2 (0–13), which was compatible with mild depression. There was no statistically significant difference between the time elapsed from diagnosis, PSA levels, smoking and alcohol habitus, major surgical history and comorbidity status, and STAI-I, STAI-II, and BDI scores (p>0.05) (Table 2 and 3).